Posted: May 03, 2022
CURRENT MOU IS SUSPENDED, AGENCY WILL UNDERTAKE FORMAL RULEMAKING
Posted: July 08, 2020
The Alliance for Pharmacy Compounding held their Advocacy Town Hall, which you can watch in its entirety...
Posted: June 25, 2020
A recent clinical trial from the UK showed decreased mortality for patients seriously ill with COVID-19 requiring oxygen or ventilators when treatment included the corticosteroid dexamethasone...
Posted: June 05, 2020
This week, two major medical journals retracted separate studies on Covid-19 treatments due to an inability to validate the data and methodology used in the studies.
Posted: April 21, 2020
Covid-19 has led to a constantly changing regulatory environment to support patient care. But pharmacists need to take care to monitor national as well as state laws and guidelines.
Posted: April 15, 2020
Compounders and other pharmacy workers are essential to keeping their communities safe and healthy, especially during the current public health crisis.
Posted: April 10, 2020
The search for an effective treatment of the COVID-19 virus has cast a broad net...
Posted: April 01, 2020
Formulas from the FDA, USP, and WHO
Posted: September 25, 2019
While revisions to chapters <795> and <797> will be delayed, USP <800> will still take effect December 1, 2019.
Posted: June 01, 2019Tags: iacp, compounding industry news, advocacy
The FDA issued a guidance on May 24, 2019...